Abstract
Preclinical Research The objective of this study was to evaluate the pharmacological antihyperalgesic interaction between N-palmitoylethanolamide (PEA) and acetaminophen in diabetic rats using the formalin paw test. Streptozotocin (STZ)-induced diabetic rats received subcutaneous injections in the paw of PEA alone (1-100 μg/paw) or acetaminophen alone (3-300 μg/paw) 15 min before formalin (0.5%) injection. The results revealed concentration-dependent responses produced by PEA (EC50 = 7.19 ± 0.7 μg/paw) and acetaminophen (EC50 = 57.9 ± 1.9 μg/paw). Isobolographic analysis was used to evaluate the pharmacological interaction between the PEA + acetaminophen using the EC50 value and a fixed 1:1 ratio combination. The isobologram demonstrated that the combination investigated in this study produced a synergistic interaction; the experimental value (EC50= 23.64 ± 1.9 μg/paw) was significantly smaller than those that resulted from theoretical calculations (EC50 = 32.56 μg/paw). These results provide evidence that PEA in combination with acetaminophen could be useful for pain therapy in neuropathic diabetic patients. Drug Dev Res 76: 228-234, 2015.
Original language | English |
---|---|
Pages (from-to) | 228-234 |
Number of pages | 7 |
Journal | Drug Development Research |
Volume | 76 |
Issue number | 5 |
DOIs | |
State | Published - 1 Aug 2015 |
Keywords
- N-palmitoylethanolamide
- acetaminophen
- antihyperalgesia
- diabetic neuropathy
- synergism